作者
John J.V. McMurray,Scott D. Solomon,Silvio E. Inzucchi,Lars Køber,Mikhail Kosiborod,Felipe A. Martínez,Piotr Ponikowski,Marc S. Sabatine,Inder S. Anand,Jan Bělohlávek,Michael Böhm,Chern‐En Chiang,Vijay Chopra,Rudolf A. de Boer,Akshay S. Desai,Mirta Díez,Jarosław Dróżdż,Andrej Dukát,Junbo Ge,Jonathan G. Howlett,Tzvetana Katova,Masafumi Kitakaze,Charlotta Ljungman,Béla Merkely,Stephen D. Wiviott,Eileen O’Meara,Mark C. Petrie,Pham Nguyễn Vinh,Morten Schou,С. Н. Терещенко,Subodh Verma,Claes Held,David L. DeMets,Kieran F. Docherty,Pardeep S. Jhund,Olof Bengtsson,Mikaela Sjöstrand,AM Langkilde
摘要
In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of SGLT2 inhibitors in patients with established heart failure and a reduced ejection fraction, regardless of the presence or absence of type 2 diabetes.
寻道图强
AireenBeryl531
浅尝离白
JY
清脆松
Singularity
tuanheqi
8R60d8
shinysparrow
美好乐松
研友_ZAVbe8
传奇3
西罗
安安
华仔
快乐抽屉
genomed
小王
CipherSage
大模型
皖公网安备34019202002308
